Tour leader tests positive for salbutamol

Igor Gonzalez Galdeano, who has led the Tour de France for the last six stages, has tested positive for the restricted substance salbutamol.

Igor Gonzalez Galdeano, who has led the Tour de France for the last six stages, has tested positive for the restricted substance salbutamol.

The UCI, world cycling's governing body, said Galdeano has "the necessary justifications" to take the substance, Sudres said.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Sport

Newsletter

Sign up to our daily sports bulletin, delivered straight to your inbox at 5pm. Subscribers also receive an exclusive email from our sports desk editors every Friday evening looking forward to the weekend's sporting action.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited